StemCell Institute 7096
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- JPY 1,875.00
- Day Range
- JPY 1,806.00–1,890.00
- 52-Week Range
- JPY 1,728.00–3,285.00
- Bid/Ask
- JPY 1,824.00 / JPY 1,889.00
- Market Cap
- JPY 18.88 Bil
- Volume/Avg
- 5,800 / 20,295
Key Statistics
- Price/Earnings (Normalized)
- 47.78
- Price/Sales
- 7.88
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
StemCell Institute is engaged in Cell bank business that separates and stores cord blood for regenerative medicine. Cord blood is the baby's blood contained in the umbilical cord and placenta that connects mother and baby. In its umbilical cord blood storage business, upon receiving notification from customers who have contracted, umbilical cord blood collected at obstetric facilities throughout Japan is collected, transported to the company's own cell processing center within 48 hours, and it provides a service to store cells at ultra-low temperature after separating cells from blood.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Growth
- Total Number of Employees
- 168
- Website
- https://www.stemcell.co.jp
Comparables
Valuation
|
Metric
|
7096
|
4978
|
600645
|
|---|---|---|---|
Price/Earnings (Normalized) | 47.78 | — | 64.35 |
Price/Book Value | 7.29 | 1.49 | 2.08 |
Price/Sales | 7.88 | 4.57 | 4.87 |
Price/Cash Flow | 54.47 | — | 28.58 |
Price/Earnings
7096
4978
600645
Financial Strength
|
Metric
|
7096
|
4978
|
600645
|
|---|---|---|---|
Quick Ratio | 1.17 | 11.63 | 1.46 |
Current Ratio | 1.20 | 12.43 | 1.70 |
Interest Coverage | — | — | 135.16 |
Quick Ratio
7096
4978
600645
Profitability
|
Metric
|
7096
|
4978
|
600645
|
|---|---|---|---|
Return on Assets (Normalized) | 6.65% | −0.30% | — |
Return on Equity (Normalized) | 16.43% | −0.32% | — |
Return on Invested Capital (Normalized) | 16.34% | −0.82% | — |
Return on Assets
7096
4978
600645
Biotechnology Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
NVO
| Novo Nordisk A/S ADR | Hkhpxttzg | Hsmh | $554.7 Bil | |
VRTX
| Vertex Pharmaceuticals Inc | Spkydqgb | Gkvdgx | $102.7 Bil | |
REGN
| Regeneron Pharmaceuticals Inc | Qglxkhv | Ywdgnd | $97.8 Bil | |
MRNA
| Moderna Inc | Fdwnwzyhs | Jqc | $41.3 Bil | |
ARGX
| argenx SE ADR | Khkkqll | Lgcw | $22.3 Bil | |
BNTX
| BioNTech SE ADR | Ndmsgjys | Mhrv | $21.0 Bil | |
ALNY
| Alnylam Pharmaceuticals Inc | Hrskxhwb | Btzvv | $18.2 Bil | |
BMRN
| Biomarin Pharmaceutical Inc | Vtjqxscw | Vbmtzm | $15.4 Bil | |
RPRX
| Royalty Pharma PLC Class A | Xjqrjhmnld | Nhqdpx | $12.5 Bil | |
INCY
| Incyte Corp | Mhfrcdkm | Hbjzp | $11.6 Bil |